KLOW Blend (80mg Total Peptide)

The KLOW Blend is an advanced synergetic 4-peptide complex engineered for comprehensive, multi-pathway tissue repair and regenerative research. Formulated with 80 mg total peptide content per vial, KLOW merges four of the most widely investigated research peptides into a unified matrix: GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg), and KPV (10 mg).

By targeting complementary cellular pathways simultaneously, KLOW enables researchers to evaluate synergistic responses in cell migration, angiogenesis, collagen deposition, and inflammatory cytokine suppression within a single experimental model. True Lab Peptides supplies the KLOW Blend at an independently verified purity threshold of $\ge$99%, offering research institutions a reliable standard for high-precision analytical studies.

Individual Component Profile

• GHK-Cu (50 mg): A copper-binding tripeptide (Gly-His-Lys) studied for its ability to stimulate extracellular matrix (ECM) synthesis, promote collagen/elastin expression, and support dermal fibroblast migration.

• BPC-157 (10 mg): A synthetic 15-amino-acid pentadecapeptide researched for its angiogenic upregulation, VEGFR2 activation, and structural repair in tendon, ligament, muscle, and mucosal tissue models.

• TB-500 / Thymosin $\beta_4$ Fragment (10 mg): An actin-binding peptide studied for promoting cell motility, cytoskeletal remodeling, rapid cell migration, and reducing fibrotic tissue formation.

• KPV (10 mg): An $\alpha$-MSH-derived tripeptide (Lys-Pro-Val) evaluated for its potent NF-$\kappa$B and MAP-kinase pathway inhibition, effectively blunting pro-inflammatory cytokine expression (TNF-$\alpha$, IL-6).

Key Research Applications

• Multi-Pathway Tissue Regeneration: Engineered to investigate concurrent angiogenic signaling, fibroblast migration, and cytoskeletal remodeling across tendon, muscle, and dermal models.

• Extracellular Matrix (ECM) Synthesis: Ideal for evaluating gene expression shifts related to collagen Type I and III formation, fibronectin deposition, and tissue remodeling kinetics.

• Inflammatory Cascade Modulation: Utilized to observe down-regulation of NF-$\kappa$B signaling and inhibition of pro-inflammatory cytokines in tissue injury assays.

• Analytical Characterization: Serves as a high-grade reference blend for High-Performance Liquid Chromatography (HPLC) and quantitative mass spectrometry workflows.

Technical Specifications

• Compound Name: KLOW Blend (GHK-Cu / BPC-157 / TB-500 / KPV)

• Formulation Composition: GHK-Cu (50 mg), BPC-157 (10 mg), TB-500 (10 mg), KPV (10 mg)

• CAS Number: Multi-component mixture (Not individually assigned as a blend)

• Purity Grade: $\ge$99% (COA-Verified)

• Physical Form: Lyophilized Powder

• Net Quantity: 80 mg total peptide content per vial

• Category Focus: Tissue Response & Regenerative Pathway Research

Quality Assurance & Laboratory Protocols

Every batch of the KLOW Blend undergoes rigorous third-party analytical validation—including High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS)—to confirm multi-peptide sequence identity, component ratio precision, and overall purity standards. Batch-specific Certificates of Analysis (COA) and Safety Data Sheets (SDS) are accessible to support full institutional research compliance.

Storage Instructions: Store unopened lyophilized vials in a dry, dark environment at $-20^\circ\text{C}$. Following initial reconstitution with appropriate laboratory solvents, maintain under refrigeration at $2^\circ\text{C}$ to $8^\circ\text{C}$. Refer to the product Safety Data Sheet (SDS) for complete chemical handling guidance.

Research Disclaimer: This product is strictly supplied for in vitro, analytical, and laboratory research purposes only. It is not intended for human or veterinary use, consumption, administration, injection, diagnostic procedures, or therapeutic applications.